In August 2022, (14 years after its last publication), the long-awaited EU GMP guide Annex 1 was published and comes into force on 25 August 2023. Annex 1, which includes new expectations as well as detailing the existing requirements in the 2008 publication, has been aimed to be harmonized with other updated guides. The Annex 1 guide is a versatile document that outlines the various aspects of the aseptic process as well as personnel, facilities, equipment, production, and robust technologies. Maintaining a sterile production environment on an ongoing basis is critical in the production of sterile pharmaceuticals, and strict adherence to guidelines and relevant standards is required to minimize contamination risks and ensure product quality and safety. It is very important that the production equipment, the production environment, the production process, and the criteria to be met by personnel are clearly and comprehensibly evaluated in the main GMP documents.
During this training, all changes in Annex 1 will be evaluated, and the minimum requirements that aseptic operations must meet will be discussed and presented to the participants through examples.
This course will address all current aseptic process guidance and it will provide participants with the opportunity to refresh their knowledge. How to minimize the risks of quality risk management principles will be discussed and the basics of microbiology will be explained. Environmental monitoring, bioburden and sterility assurance will be evaluated through examples, and the terms of cleaning, disinfection, sanitation and decontamination will be explained.
In Annex 1, the principles of Contamination Control Strategy (CCS), which is one of the most important expectations, will be evaluated and guidance will be given on how to prepare a sample CCS. Examples of the expectations of the health authorities regarding sterilization and visual control will be presented, and the points to be considered in Heating, Ventilation and Air Conditioning (HVAC), Water, Steam, and Gas systems will be covered.
Clean room classification, Personal Air Lock (PAL), Material Air Lock (MAL) concepts, and critical aspects in Restricted Access Barrier Systems (RABS) and Isolator systems that are starting to replace clean rooms will be evaluated. In addition, robust production techniques such as Blow Fill Seal (BFS) and Form Fill Seal (FFS) will be emphasized. The inconveniences encountered due to the violation of the microbial rules that must be followed in sterile environments due to various reasons will be conveyed with sample applications.
Important aspects of critical aseptic process simulation operations, previously known as media fill, airflow visualization study, aseptic filling, and closure will be shared with the participants.
In the last part of the training, the expectations of the health authorities of quality assurance and aseptic operations will be included, and the expectations of regulatory authorities such as FDA, MHRA, TGA, WHO, PIC/S from aseptic operations and the new Annex 1 will be addressed, and the most common deviations will be evaluated with recommendations.
Benefits of Attending
- Learn about the regulatory requirements of the revised Annex 1, its effects on aseptic production, terminal sterilization expectations and quality challenges
- Gain tips on how to overcome difficulties still experienced despite the enactment of Annex 1
- Have the opportunity to examine examples of experiences of colleagues and health authority inspectors in using Annex 1
- Examine solution proposals for the CCS
- Hear recommendations on critical topics such as environmental monitoring, cleaning and disinfection, personnel and facility hygiene
- Gain knowledge of barrier separation technologies, alternative production techniques, and regulations for processing different sterile products
- Have the opportunity to evaluate the integration of the automation applied in the production environment in terms of GMP
- Hear suggestions regarding the analysis of trends encountered in aseptic production
- Get an insight into the focus of health authority inspections in the future
In addition, under Annex 1 the qualification of aseptic production personnel, education and training requirements, and examples of personal skills they should have will be learned.
The expectations of the regulatory authorities and the questions that may be encountered in audits/inspections will also be discussed.
Certifications:
- CPD: 12 hours for your records
- Certificate of completion
Speakers
Mustafa Edik,
Independent GMP Consultant and AuditorAfter graduating as a Chemist from university, Mustafa began his 25 year plus career as a Laboratory Supervisor at Bayer, a German Pharmaceutical Company. After 15 years of working as a Quality Assurance Assistant Manager, Laboratory Supervisor, Pharmaceutical Quality Management Systems, and GMP Lead Auditor, he decided to continue his career as a Consultant. He has served the Turkish Atomic Energy Authority (TAEA) as Principal GMP Auditor and Consultant for 6 years. TAEA was audited by the Republic of Turkey Ministry of Health and granted GMP Certificate for 5 Radiopharmaceuticals. This success has won great acclaim from all health authorities and industry.
He has prepared and presented various training courses and workshops to more than 8000 individuals from 150 International and local Pharmaceutical, Medical Device, and Cosmetics companies on GMP, GDP and Pharmaceutical Quality Management Systems. He has taken part in several International Pharmaceutical Facility Establishment projects as GMP Consultant and has also set up various Quality Management Systems for Local Pharmaceutical and Medical Device Companies.
While he was the Vice President of Quality and Technical Operations at a Quality Academia Training and Consultancy firm, he acquired and converted it into a 100 % Turkish Company. As the only IRCA Certificated Pharmaceutical Quality Management Systems and GMP Lead Auditor in Turkey, he currently conducts API, Excipient, Packaging Materials Suppliers and Manufacturers, Third Party Logistics Service Providers, Sterile and Non-Sterile Manufacturing Facilities Audits according to FDA, EMA, PIC /S, TMMDA, MHRA, TGA Health Canada, and WHO regulations and guidelines.
He finished his second university degree in Biopharmaceutical Sciences BSc (Hons) at Atlantic Technological University - Ireland. He is the author of chapter 6 of the book published by PDA named “Good Distribution Practices” and he is preparing his latest book on ‘GMP Audits’ which will be published by Taylor & Francis in 2023.
Who Should Attend
Personnel in the following roles and departments:
- Quality Assurance and Quality Control Validation
- R & D
- Audit
- Regulatory
- IT
- Warehouse and supply chain
- Engineering
- Procurement
- Health Authority Inspectors
